user

An accelerated build-up phase increases the adherence to allergen subcutaneous immunotherapy. A retrospective study

被引：0
|
作者：
Caruso, C. [1 ]
Brame, B. [2 ]
Cocconcelli, A. [3 ]
Colantuono, S. [1 ,4 ]
Ortolani, V [5 ]
Pravettoni, V [6 ]
Scarpa, S. [7 ]
Zisa, G. [8 ]
机构：
[1] Presidio Columbus Fdn Policlin Univ Agostino Geme, Allergy Unit, Rome, Italy
[2] Legnano Gen Hosp, Clin Allergy & Immunol Unit, Legnano, Italy
[3] AUSL Reggio Emilia, Allergy Outpatient Clin, Reggio Emilia, Italy
[4] Sapienza Univ Rome, Dept Clin Med, Rome, Italy
[5] ASST Fatebenefratelli Sacco, Allergy & Clin Immunol Dept, Milan, Italy
[6] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Clin Allergy & Immunol Unit, Milan, Italy
[7] AUSL Parma, Clin Allergy & Immunol Unit, Parma, Italy
[8] Novara Hosp, Allergol & Immunol Unit, Novara, Italy
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
TP1204
引用
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [31] Safety and tolerability of an ultra-rush build-up phase with a high dose sublingual immunotherapy in children
    Bassi, M.
    Angrisano, A.
    [J]. ALLERGY, 2008, 63 : 227 - 228
  • [32] Safety of three cluster regimens for the build-up phase of subcutaneous immunotherapy in allergic patients receiving a standardized extract of grass and olive pollen adsorbed on aluminium hydroxide
    Sanchez, C.
    Fernandez-Tavora, L.
    Serrano, P.
    Guerra, F.
    Alva, V.
    Justicia, J.
    [J]. ALLERGY, 2007, 62 : 236 - 236
  • [33] Safety of two cluster regimens for the build-up phase of subcutaneous immunotherapy in allergic patients receiving a standardized extract of grass and olive pollen adsorbed on calcium phosphate
    Cimarra, M.
    Serrano, P.
    Martinez-Cocera, C.
    Guerra, F.
    Alva, V.
    Justicia, J.
    [J]. ALLERGY, 2007, 62 : 236 - 236
  • [34] Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy
    Korosec, P.
    Ziberna, K.
    Silar, M.
    Dezman, M.
    Smodis, N. Celesnik
    Rijavec, M.
    Kopac, P.
    Erzen, R.
    Lalek, N.
    Bajrovic, N.
    Kosnik, M.
    Zidarn, M.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (10): : 1579 - 1589
  • [35] Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase
    Stoevesandt, J.
    Hain, J.
    Stolze, I.
    Kerstan, A.
    Trautmann, A.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (05): : 747 - 755
  • [36] Tolerability of subcutaneous immunotherapy with standardized allergen extracts administered by cluster schedules:: observational, retrospective, multicentric study
    Serrano, P.
    Cimarra, M.
    Sanchez, C.
    Fernandez-Tavora, L.
    Alva, V
    Justicia, J.
    [J]. ALLERGY, 2008, 63 : 249 - 249
  • [37] A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
    Lee, Ji-Ho
    Kim, Su-Chin
    Choi, Hyunna
    Jung, Chang-Gyu
    Ban, Ga-Young
    Shin, Yoo Seob
    Nahm, Dong-Ho
    Park, Hae-Sim
    Ye, Young-Min
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2018, 10 (01) : 18 - 24
  • [38] Anaphylactic reactions in the build-up phase of rush immunotherapy for bee venom allergy in pediatric patients: a single-center experience
    Glaeser A.
    Müller C.
    Bode S.
    [J]. Clinical and Molecular Allergy, 20 (1)
  • [39] Venom immunotherapy: safety and tolerability of the build-up phase with depot versus aqueous preparations (vol 52, pg 1230, 2022)
    Pravettoni, V.
    Mauro, M.
    Rivolta, F.
    Consonni, D.
    Cappelletti, C.
    Gallo, A. Chiei
    Sangalli, A.
    Bilo, M. B.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (08): : 891 - 891
  • [40] Phase I study of subcutaneous allergen immunotherapy with Dermatophagoides pteronyssinus in patients with allergic rhinoconjunctivitis with or without asthma
    Fernandez de Rojas, Dolores Hernandez
    Antepara Ercoreca, Ignacio
    Ponte Tellechea, Ana
    Ibanez Echevarria, Ethel
    Jauregui Presa, Ignacio
    Gamboa Setien, Pedro
    Asturias, Juan A.
    Landeta Manzano, Araitz
    Madariaga Goirigolzarri, Begona
    [J]. IMMUNOTHERAPY, 2015, 7 (02) : 89 - 99
12345